Genetic factors modifying sickle cell disease severity

Sickle Cell Anemia: From Basic Science to Clinical Practice

Volumn , Issue , 2016, Pages 371-398

  Gardner, Kate ^a,b   Thein, Swee Lay ^a,b,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Genotype phenotype; GWAS; Hemoglobin F

Indexed keywords

EID: 84978194642     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-06713-1_15     Document Type: Chapter

References (174)

1. Adams RJ, Mc Kie VC, Hsu L et al (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med 339(1):5-11
2. Adewoye AH, Nolan VG, Ma Q et al (2006) Association of polymorphisms of IGF1R and genes in the transforming growth factor- beta /bone morphogenetic protein pathway with bacteremia in sickle cell anemia. Clin Infect Dis 43(5):593-598
3. Adeyoju AB, Olujohungbe AB, Morris J et al (2002) Priapism in sickle-cell disease; incidence, risk factors and complications - an international multicentre study. BJU Int 90(9):898-902
4. Alexander N, Higgs D, Dover G, Serjeant GR (2004) Are there clinical phenotypes of homozygous sickle cell disease? Br J Haematol 126(4):606-611
5. Al-Habboubi HH, Mahdi N, Abu-Hijleh TM et al (2012) The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. Eur J Haematol 89(5):403-409
6. Al-Ola K, Mahdi N, Al-Subaie AM et al (2008) Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia. Tissue Antigens 71(5):453-457
7. Alves Jacob M, da Cunha Bastos C, Regina Bonini-Domingos C (2011) The 844ins68 cystathionine beta-synthase and C677T MTHFR gene polymorphism and the vaso-occlusive event risk in sickle cell disease. Arch Med Sci 7(1):97-101
8. Amin BR, Bauersachs RM, Meiselman HJ et al (1991) Monozygotic twins with sickle cell anemia and discordant clinical courses: clinical and laboratory studies. Hemoglobin 15(4): 247-256
9. Andrade FL, Annichino-Bizzacchi JM, Saad ST, Costa FF, Arruda VR (1998) Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 59(1):46-50
10. Ashley-Koch AE, Elliott L, Kail ME et al (2008) Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease. Blood 111(12):5721-5726
11. Ashley-Koch AE, Okocha EC, Garrett ME et al (2011) MYH9 and APOL1 are both associated with sickle cell disease nephropathy. Br J Haematol 155(3):386-394
12. Attalla BA, Karrar ZA, Ibnouf G et al (2013) Outcome of cholelithiasis in Sudanese children with Sickle Cell Anaemia (SCA) after 13 years follow-up. Afr Health Sci 13(1):154-159
13. Badens C, Joly P, Agouti I et al (2011) Variants in genetic modifiers of beta-thalassemia can help to predict the major or intermedia type of the disease. Haematologica 96(11):1712-1714
14. Bae HT, Baldwin CT, Sebastiani P et al (2012) Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 120(9):1961-1962
15. Baldwin C, Nolan VG, Wyszynski DF et al (2005) Association of klotho, bone morphogenic protein 6, and annexin A2 polymorphisms with sickle cell osteonecrosis. Blood 106(1):372-375
16. Ballas SK (2001) Effect of alpha-globin genotype on the pathophysiology of sickle cell disease. Pediatr Pathol Mol Med 20(2):107-121
17. Ballas SK (2007) Current issues in sickle cell pain and its management. Hematology Am Soc Hematol Educ Program 97-105
18. Ballas SK, Kesen MR, Goldberg MF et al (2012) Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management. ScientificWorldJournal 2012:949535
19. Bamshad MJ, Ng SB, Bigham AW et al (2011) Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 12(11):745-755
20. Bauer DE, Kamran SC, Lessard S et al (2013) An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342(6155):253-257
21. Bean CJ, Boulet SL, Ellingsen D et al (2012) Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood 120(18):3822-3828
22. Becton LJ, Kalpatthi RV, Rackoff E et al (2010) Prevalence and clinical correlates of microalbuminuria in children with sickle cell disease. Pediatr Nephrol 25(8):1505-1511
23. Belisario AR, Nogueira FL, Rodrigues RS et al (2015) Association of alpha-thalassemia, TNF-alpha (-308G>A) and VCAM-1 (c.1238G>C) gene polymorphisms with cerebrovascular disease in a newborn cohort of 411 children with sickle cell anemia. Blood Cells Mol Dis 54(1):44-50
24. Bernaudin F, Verlhac S, Chevret S et al (2008) G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 112(10):4314-4317
25. Bhatnagar P, Purvis S, Barron-Casella E et al (2011) Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients. J Hum Genet 56(4):316-323
26. Bianchi E, Zini R, Salati S et al (2010) c-Myb supports erythropoiesis through the transactivation of KLF1 and LMO2 expression. Blood 116(22):e99-e110
27. Bonham VL, Dover GJ, Brody LC (2010) Screening student athletes for sickle cell trait--a social and clinical experiment. N Engl J Med 363(11):997-999
28. Borg J, Papadopoulos P, Georgitsi M et al (2010) Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin. Nat Genet 42(9):801-805
29. Borg J, Patrinos GP, Felice AE, Philipsen S (2011) Erythroid phenotypes associated with KLF1 mutations. Haematologica 96(5):635-638
30. Bouanga JC, Mouele R, Prehu C et al (1998) Glucose-6-phosphate dehydrogenase deficiency and homozygous sickle cell disease in Congo. Hum Hered 48(4):192-197
31. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH (2004) Sickle cell disease. Hematology Am Soc Hematol Educ Program 35-47
32. Cajado C, Cerqueira BA, Couto FD et al (2011) TNF-alpha and IL-8: serum levels and gene polymorphisms (-308G>A and -251A>T) are associated with classical biomarkers and medical history in children with sickle cell anemia. Cytokine 56(2):312-317
33. Callahan JF, Burgess JL, Fornwald JA et al (2002) Identification of novel inhibitors of the transforming growth factor beta1 (TGF-beta1) type 1 receptor (ALK5). J Med Chem 45(5): 999-1001
34. Castro V, Alberto FL, Costa RN et al (2004) Polymorphism of the human platelet antigen-5 system is a risk factor for occlusive vascular complications in patients with sickle cell anemia. Vox Sang 87(2):118-123
35. Cordero EA, Veit TD, da Silva MA et al (2009) HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 74(4):308-313
36. Costa RN, Conran N, Albuquerque DM et al (2005) Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia. Haematologica 90(7):977-979
37. Cox SE, Makani J, Soka D et al (2014) Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania. Br J Haematol 165(5):699-706
38. Craig JE, Rochette J, Fisher CA et al (1996) Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach. Nat Genet 12(1):58-64
39. Curro G, Meo A, Ippolito D, Pusiol A, Cucinotta E (2007) Asymptomatic cholelithiasis in children with sickle cell disease: early or delayed cholecystectomy? Ann Surg 245(1):126-129
40. Dampier C, Ely E, Eggleston B, Brodecki D, O’Neal P (2004) Physical and cognitive-behavioral activities used in the home management of sickle pain: a daily diary study in children and adolescents. Pediatr Blood Cancer 43(6):674-678
41. Day TG, Drasar ER, Fulford T, Sharpe CC, Thein SL (2012) Association between hemolysis and albuminuria in adults with sickle cell anemia. Haematologica 97(2):201-205
42. del Giudice EM, Perrotta S, Nobili B et al (1999) Coinheritance of Gilbert syndrome increases the risk for developing gallstones in patients with hereditary spherocytosis. Blood 94(7): 2259-2262
43. Dossou-Yovo OP, Zaccaria I, Benkerrou M et al (2009) Effects of RANTES and MBL2 gene polymorphisms in sickle cell disease clinical outcomes: association of the g.In1.1T>C RANTES variant with protection against infections. Am J Hematol 84(6):378-380
44. Drasar ER, Menzel S, Fulford T, Thein SL (2013) The effect of Duffy antigen receptor for chemo-kines on severity in sickle cell disease. Haematologica 98(8):e87-e89
45. Driscoll MC, Hurlet A, Styles L et al (2003) Stroke risk in siblings with sickle cell anemia. Blood 101(6):2401-2404
46. El-Hazmi MA (1992) Clinical and haematological diversity of sickle cell disease in Saudi children. J Trop Pediatr 38(3):106-112
47. Elliott L, Ashley-Koch AE, De Castro L et al (2007) Genetic polymorphisms associated with priapism in sickle cell disease. Br J Haematol 137(3):262-267
48. Embury SH, Dozy AM, Miller J et al (1982) Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med 306(5):270-274
49. Embury SH, Hebbel RP, Mohandas N, Steinberg MH (eds) (1994) Sickle cell disease: basic principles and clinical practice. Raven, New York
50. Esteghamat F, Gillemans N, Bilic I et al (2013) Erythropoiesis and globin switching in compound Klf1::Bcl11a mutant mice. Blood 121(13):2553-2562
51. Farrell JJ, Sherva RM, Chen ZY et al (2011) A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression. Blood 117(18):4935-4945
52. Fertrin KY, Melo MB, Assis AM, Saad ST, Costa FF (2003) UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia. Clin Genet 64(2):160-162
53. Figueiredo MS, Kerbauy J, Goncalves MS et al (1996) Effect of alpha-thalassemia and beta-globin gene cluster haplotypes on the hematological and clinical features of sickle-cell anemia in Brazil. Am J Hematol 53(2):72-76
54. Flanagan JM, Frohlich DM, Howard TA et al (2011) Genetic predictors for stroke in children with sickle cell anemia. Blood 117(24):6681-6684
55. Flanagan JM, Sheehan V, Linder H et al (2013) Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia. Blood 121(16):3237-3245
56. Galanello R, Piras S, Barella S et al (2001) Cholelithiasis and Gilbert’s syndrome in homozygous beta-thalassaemia. Br J Haematol 115(4):926-928
57. Galanello R, Sanna S, Perseu L et al (2009) Amelioration of Sardinian beta-zero thalassemia by genetic modifiers. Blood 114(18):3935-3937
58. Galarneau G, Palmer CD, Sankaran VG et al (2010) Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation. Nat Genet 40(12):1049-1051
59. Galarneau G, Coady S, Garrett ME et al (2013) Gene-centric association study of acute chest syndrome and painful crisis in sickle cell disease patients. Blood 122(3):434-442
60. Garner C, Tatu T, Reittie JE et al (2000) Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 95(1):342-346
61. Genovese G, Friedman DJ, Ross MD et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 329(5993):841-845
62. Gladwin MT, Sachdev V, Jison ML et al (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 350(9):886-895
63. Goldstein J, Konigsberg W, Hill RJ (1963) The structure of human hemoglobin. VI. The sequence of amino acids in the tryptic peptides of the beta chain. J Biol Chem 238:2016-2027
64. Green NS, Ender KL, Pashankar F et al (2013) Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea. PLoS One 8(2):e55709
65. Heeney MM, Howard TA, Zimmerman SA, Ware RE (2003) UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia. J Lab Clin Med 141(4):279-282
66. Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6(2):95-108
67. Hoppe C, Klitz W, Noble J et al (2003) Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood 101(7):2865-2869
68. Hoppe C, Klitz W, Cheng S et al (2004) Gene interactions and stroke risk in children with sickle cell anemia. Blood 103(6):2391-2396
69. 1 trisomy syndrome. Proc Natl Acad Sci U S A 51:89-97
70. Ingram VM (1957) Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180(4581):326-328
71. Jawaid K, Wahlberg K, Thein SL, Best S (2010) Binding patterns of BCL11A in the globin and GATA1 loci and characterization of the BCL11A fetal hemoglobin locus. Blood Cells Mol Dis 45(2):140-146
72. Jiang J, Best S, Menzel S et al (2006) cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 108(3):1077-1083
73. Joishy SK, Griner PF, Rowley PT (1976) Sickle b-thalassemia: identical twins differing in severity implicate nongenetic factors influencing course. Am J Hematol 1(1):23-33
74. Kutlar A, Kutlar F, Turker I, Tural C (2001) The methylene tetrahydrofolate reductase (C677T) mutation as a potential risk factor for avascular necrosis in sickle cell disease. Hemoglobin 25(2):213-217
75. Labie D, Pagnier J, Lapoumeroulie C et al (1985) Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients. Proc Natl Acad Sci U S A 82(7):2111-2114
76. Lettre G, Sankaran VG, Bezerra MA et al (2008) DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc Natl Acad Sci U S A 105(33):11869-11874
77. Machado RD, Pauciulo MW, Thomson JR et al (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68(1):92-102
78. Magor GW, Tallack MR, Gillinder KR et al (2015) KLF1 null neonates display hydrops fetalis and a deranged erythroid transcriptome. Blood 125:2405-2417
79. Maier-Redelsperger M, Levy P, Lionnet F et al (2010) Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia. Blood Cells Mol Dis 45(4):289-292
80. Makani J, Menzel S, Nkya S et al (2011) Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia. Blood 117(4):1390-1392
81. Manolio TA (2013) Bringing genome-wide association findings into clinical use. Nat Rev Genet 14(8):549-558
82. Mendonga TF, Oliveira MC, Vasconcelos LR et al (2010) Association of variant alleles of MBL2 gene with vasoocclusive crisis in children with sickle cell anemia. Blood Cells Mol Dis 44(4): 224-228
83. Menzel S, Garner C, Gut I et al (2007a) A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet 39(10):1197-1199
84. Menzel S, Jiang J, Silver N et al (2007b) The HBS1L-MYB intergenic region on chromosome 6q23.3 influences erythrocyte, platelet, and monocyte counts in humans. Blood 110(10): 3624-3626
85. Menzel S, Garner C, Rooks H, Spector TD, Thein SL (2013) HbA2 levels in normal adults are influenced by two distinct genetic mechanisms. Br J Haematol 160(1):101-105
86. Menzel S, Rooks H, Zelenika D et al (2014) Global genetic architecture of an erythroid quantitative trait locus, HMIP-2. Ann Hum Genet 78:434-451
87. Miller IJ, Bieker JJ (1993) A novel, erythroid cell-specific murine transcription factor that binds to the CACCC element and is related to the KrUppel family of nuclear proteins. Mol Cell Biol 13(5):2776-2786
88. Miller ST, Sleeper LA, Pegelow CH et al (2000) Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med 342(2):83-89
89. Milton JN, Sebastiani P, Solovieff N et al (2012) A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. PLoS One 7(4):e34741
90. Mtatiro SN, Singh T, Rooks H et al (2014) Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania. PLoS One 9(11):e111464
91. Nagel RL, Fabry ME, Pagnier J et al (1985) Hematologically and genetically distinct forms of sickle cell anemia in Africa. The Senegal type and the Benin type. N Engl J Med 312(14):880-884
92. Gg and Hb F level. Blood 69:1026-1030
93. Nagel RL, Erlingsson S, Fabry ME et al (1991) The Senegal DNA haplotype is associated with the amelioration of anemia in African-American sickle cell anemia patients. Blood 77: 1371-1375
94. Nath KA, Hebbel RP (2015) Sickle cell disease: renal manifestations and mechanisms. Nat Rev Nephrol 11(3):161-171
95. National Institutes of Health: National Heart Lung and Blood Institute (2014) Evidence-based management of sickle cell disease NIH Expert Panel Report
96. Nebor D, Broquere C, Brudey K et al (2010a) Alpha-thalassemia is associated with a decreased occurrence and a delayed age-at-onset of albuminuria in sickle cell anemia patients. Blood Cells Mol Dis 45(2):154-158
97. Nebor D, Durpes MC, Mougenel D et al (2010b) Association between Duffy antigen receptor for chemokines expression and levels of inflammation markers in sickle cell anemia patients. Clin Immunol 136(1):116-122
98. Neonato MG, Lu CY, Guilloud-Bataille M et al (1999) Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet 7(6):679-686
99. Nishank SS, Singh MP, Yadav R et al (2013) Endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease patients in India. J Hum Genet 58(12):775-779
100. Noguchi CT, Torchia DA, Schechter AN (1983) Intracellular polymerization of sickle hemoglobin. Effects of cell heterogeneity. J Clin Invest 72(3):846-852
101. Noguchi CT, Rodgers GP, Serjeant G, Schechter AN (1988) Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 318(2):96-99
102. Nolan VG, Baldwin C, Ma Q et al (2005) Association of single nucleotide polymorphisms in klotho with priapism in sickle cell anaemia. Br J Haematol 128(2):266-272
103. Nolan VG, Adewoye A, Baldwin C et al (2006) Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br J Haematol 133(5):570-578
104. Ofori-Acquah SF, Lalloz MR, Layton DM (2001) Nucleotide variation regulates the level of enhancement by hypersensitive site 2 of the beta-globin locus control region. Blood Cells Mol Dis 27(5):803-811
105. Oliveira MC, Mendonca TF, Vasconcelos LR et al (2009) Association of the MBL2 gene EXON1 polymorphism and vasoocclusive crisis in patients with sickle cell anemia. Acta Haematol 121(4):212-215
106. Passon RG, Howard TA, Zimmerman SA, Schultz WH, Ware RE (2001) Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia. J Pediatr Hematol Oncol 23(7):448-451
107. Pauling L, Itano HA et al (1949) Sickle cell anemia, a molecular disease. Science 109(2835):443
108. Platt OS, Thorington BD, Brambilla DJ et al (1991) Pain in sickle cell disease: rates and risk factors. N Engl J Med 325(1):11-16
109. Platt OS, Brambilla DJ, Rosse WF et al (1994) Mortality in sickle cell disease: life expectancy and risk factors for early death. N Engl J Med 330(23):1639-1644
110. Powars DR (1991) Beta s-gene-cluster haplotypes in sickle cell anemia. Clinical and hematologic features. Hematol Oncol Clin North Am 5(3):475-493
111. Premawardhena A, Fisher CA, Fathiu F et al (2001) Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia. Lancet 357(9272):1945-1946
112. Rees DC, Lambert C, Cooper E et al (2009) Glucose 6 phosphate dehydrogenase deficiency is not associated with cerebrovascular disease in children with sickle cell anemia. Blood 114(3):742-743, author reply 743-744
113. Rees DC, Williams TN, Gladwin MT (2010) Sickle-cell disease. Lancet 376(9757):2018-2031
114. Sankaran VG, Menne TF, Xu J et al (2008) Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 322(5909):1839-1842
115. Sankaran VG, Xu J, Orkin SH (2010) Advances in the understanding of haemoglobin switching. Br J Haematol 149(2):181-194
116. Sankaran VG, Menne TF, Scepanovic D et al (2011) MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci U S A 108(4):1519-1524
117. Sankaran VG, Joshi M, Agrawal A et al (2013) Rare complete loss of function provides insight into a pleiotropic genome-wide association study locus. Blood 122(23):3845-3847
118. Sebastiani P, Nolan VG, Baldwin CT et al (2007) A network model to predict the risk of death in sickle cell disease. Blood 110(7):2727-2735
119. Sebastiani P, Solovieff N, Hartley SW et al (2010) Genetic modifiers of the severity of sickle cell anemia identified through a genome-wide association study. Am J Hematol 85(1):29-35
120. Serjeant GR, Serjeant BE (2001) Sickle cell disease, 3rd edn. Oxford University Press, Oxford
121. Serjeant GR, Higgs DR, Hambleton IR (2007) Elderly survivors with homozygous sickle cell disease. N Engl J Med 356(6):642-643
122. Sharan K, Surrey S, Ballas S et al (2004) Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br J Haematol 124(2):240-243
123. Sharpe CC, Thein SL (2014) How I treat renal complications in sickle cell disease. Blood 123(24):3720-3726
124. Shiba HF, El-Ghamrawy MK, Shaheen IA, Ali RA, Mousa SM (2014) Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, and GSTP1) in Egyptian pediatric patients with sickle cell disease. Pediatr Dev Pathol 17(4):265-270
125. Siatecka M, Bieker JJ (2011) The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood 118(8):2044-2054
126. Smith-Whitley K, Pace BS (2007) Sickle cell disease: a phenotypic patchwork. In: Pace BS (ed) Renaissance of sickle cell disease research in the genome era, 1st edn. Imperial College Press, London, pp 45-67
127. Soranzo N, Spector TD, Mangino M et al (2009) A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 41(11):1182-1190
128. Stadhouders R, Thongjuea S, Andrieu-Soler C et al (2012) Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development. EMBO J 31(4): 986-999
129. Stadhouders R, Aktuna S, Thongjuea S et al (2014) HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J Clin Invest 124(4):1699-1710
130. Stamatoyannopoulos G (2005) Control of globin gene expression during development and ery-throid differentiation. Exp Hematol 33(3):259-271
131. Steinberg MH (2009) Genetic etiologies for phenotypic diversity in sickle cell anemia. ScientificWorldJournal 9:46-67
132. Steinberg MH, Embury SH (1986) Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene. Blood 68(5):985-990
133. Steinberg MH, Sebastiani P (2012) Genetic modifiers of sickle cell disease. Am J Hematol 87(8):795-803
134. Steinberg MH, West MS, Gallagher D, Mentzer W (1988) Effects of glucose-6-phosphate dehydrogenase deficiency upon sickle cell anemia. Blood 71(3):748-752
135. Steinberg MH, Lu ZH, Barton FB et al (1997) Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood 89(3):1078-1088
136. Styles LA, Hoppe C, Klitz W et al (2000) Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood 95(11):3562-3567
137. Sullivan KJ, Kissoon N, Duckworth LJ et al (2001) Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am J Respir Crit Care Med 164(12):2186-2190
138. Suzuki M, Yamazaki H, Mukai HY et al (2013) Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model. Mol Cell Biol 33(8):1687-1695
139. Suzuki M, Yamamoto M, Engel JD (2014) Fetal globin gene repressors as drug targets for molecular therapies to treat the beta-globinopathies. Mol Cell Biol 34(19):3560-3569
140. Tallack MR, Perkins AC (2013) Three fingers on the switch: Kruppel-like factor 1 regulation of gamma-globin to beta-globin gene switching. Curr Opin Hematol 20(3):193-200
141. Tamouza R, Neonato MG, Busson M et al (2002) Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 63(3):194-199
142. Tamouza R, Busson M, Fortier C et al (2007) HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Hum Immunol 68(10):849-853
143. Tang DC, Prauner R, Liu W et al (2001) Polymorphisms within the angiotensinogen gene (GT-repeat) and the risk of stroke in pediatric patients with sickle cell disease: a case-control study. Am J Hematol 68(3):164-169
144. Tantawy AA, Adly AA, Ismail EA, Aly SH (2015) Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in sickle cell disease: relation to vasculopathy and disease severity. Pediatr Blood Cancer 62(3):389-394
145. Taylor JG, Tang DC, Savage SA et al (2002) Variants in the VCAM1 gene and risk for symptomatic stroke in sickle cell disease. Blood 100(13):4303-4309
146. Taylor JG, Nolan VG, Mendelsohn L et al (2008) Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 3(5):e2095
147. Thangarajh M, Yang G, Fuchs D et al (2012) Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Br J Haematol 159(3):352-359
148. Thein SL (2011) Genetic modifiers of sickle cell disease. Hemoglobin 35(5-6):589-606
149. Thein SL, Craig JE (1998) Genetics of Hb F/F cell variance in adults and heterocellular hereditary persistence of fetal hemoglobin. Hemoglobin 22:401-414
150. Thein SL, Menzel S (2009) Discovering the genetics underlying foetal haemoglobin production in adults. Br J Haematol 145(4):455-467
151. Thein SL, Menzel S, Peng X et al (2007) Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc Natl Acad Sci U S A 104(27):11346-11351
152. Thein SL, Menzel S, Lathrop M, Garner C (2009) Control of fetal hemoglobin: new insights emerging from genomics and clinical implications. Hum Mol Genet 18(R2):R216-R223
153. Thomas PW, Higgs DR, Serjeant GR (1997) Benign clinical course in homozygous sickle cell disease: a search for predictors. J Clin Epidemiol 50(2):121-126
154. Uda M, Galanello R, Sanna S et al (2008) Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci U S A 105(5):1620-1625
155. Ulug P, Vasavda N, Awogbade M et al (2009) Association of sickle avascular necrosis with bone morphogenic protein 6. Ann Hematol 88(8):803-805
156. van der Harst P, Zhang W, Mateo Leach I et al (2012) Seventy-five genetic loci influencing the human red blood cell. Nature 492(7429):369-375
157. Vasavda N, Menzel S, Kondaveeti S et al (2007) The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease. Br J Haematol 138(2):263-270
158. Vasavda N, Badiger S, Rees D et al (2008) The presence of alpha-thalassaemia trait blunts the response to hydroxycarbamide in patients with sickle cell disease. Br J Haematol 143(4): 589-592
159. Vicari P, Adegoke SA, Mazzotti DR et al (2015) Interleukin-1beta and interleukin-6 gene polymorphisms are associated with manifestations of sickle cell anemia. Blood Cells Mol Dis 54(3): 244-249
160. Viprakasit V, Ekwattanakit S, Riolueang S et al (2014) Mutations in Kruppel-like factor 1 cause transfusion-dependent hemolytic anemia and persistence of embryonic globin gene expression. Blood 123:1586-1595
161. Wang WC, Pavlakis SG, Helton KJ et al (2008) MRI abnormalities of the brain in one-year-old children with sickle cell anemia. Pediatr Blood Cancer 51(5):643-646
162. Ware RE (2010) How I use hydroxyurea to treat young patients with sickle cell anemia. Blood 115(26):5300-5311
163. Ware RE, Eggleston B, Redding-Lallinger R et al (2002) Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy. Blood 99(1):10-14
164. Weatherall MW, Higgs DR, Weiss H, Weatherall DJ, Serjeant GR (2005) Phenotype/genotype relationships in sickle cell disease: a pilot twin study. Clin Lab Haematol 27(6): 384-390
165. Welch JJ, Watts JA, Vakoc CR et al (2004) Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104(10):3136-3147
166. Wilber A, Nienhuis AW, Persons DA (2011) Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood 117(15):3945-3953
167. Wonkam A, Ngo Bitoungui VJ, Vorster AA et al (2014) Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon. PLoS One 9(3):e92506
168. Xu J, Sankaran VG, Ni M et al (2010) Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev 24(8):783-798
169. Xu J, Peng C, Sankaran VG et al (2011) Correction of sickle cell disease in adult mice by interference with fetal hemoglobin silencing. Science 334(6058):993-996
170. Xu J, Bauer DE, Kerenyi MA et al (2013) Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A. Proc Natl Acad Sci U S A 110(16):6518-6523
171. Yawn BP, Buchanan GR, Afenyi-Annan AN et al (2014) Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA 312(10):1033-1048
172. Zhang X, Zhang W, Ma SF et al (2014) Hypoxic response contributes to altered gene expression and precapillary pulmonary hypertension in patients with sickle cell disease. Circulation 129(16):1650-1658
173. Zhou D, Liu K, Sun CW, Pawlik KM, Townes TM (2010) KLF1 regulates BCL11A expression and gamma- to beta-globin gene switching. Nat Genet 42(9):742-744
174. Zimmerman SA, Ware RE (1998) Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 59(4):267-272